SARS-CoV-2 infection has led to a global health crisis, and yet our understanding of the
disease and potential treatment options remains limited. The infection occurs through binding of …

Individuals with coronavirus disease 2019 (COVID-19) frequently develop neurological
symptoms, but the biological underpinnings of these phenomena are unknown. Through single-…

We evaluated the performance of the Abbott BinaxNOW rapid antigen test for coronavirus
disease 2019 (Binax-CoV2) to detect virus among persons, regardless of symptoms, at a …

We evaluated the performance of the Abbott BinaxNOW™ Covid-19 rapid antigen test to
detect virus among persons, regardless of symptoms, at a public plaza site of ongoing …

The identification of autoantigens remains a critical challenge for understanding and
treating autoimmune diseases. Autoimmune polyendocrine syndrome type 1 (APS1), a rare …

Antiretroviral therapy (ART) is successful in the suppression of HIV but cannot target and
eradicate the latent proviral reservoir. The location of retroviral integration into the human …

The wide spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants with phenotypes impacting transmission and antibody sensitivity necessitates …

Secondary bacterial infections, including ventilator-associated pneumonia (VAP), lead to
worse clinical outcomes and increased mortality following viral respiratory infections including …

Genomic and proteomic screens have identified numerous host factors of SARS-CoV-2, but
efficient delineation of their molecular roles during infection remains a challenge. Here we …

Spinal muscular atrophy (SMA) is caused by defects in the survival motor neuron 1 (SMN1)
gene that encodes survival motor neuron (SMN) protein. The majority of therapeutic …